Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 333 | 466 | 390 | 221 | 389 |
| Operating Income | -333 | -466 | -390 | -221 | -389 |
| Interest Expense | 73 | 225 | 67 | 70 | 95 |
| Other Income | 10 | 10 | 28 | 1 | 11 |
| Pre-tax Income | -396 | -681 | -430 | -290 | -473 |
| Net Income Continuous | -396 | -681 | -430 | -290 | -473 |
| Net Income | $-396 | $-681 | $-430 | $-290 | $-473 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-208 | $-461 | $-384 | $-212 | $-343 |